The Chi-square test showed that the patients with AFP >300 ng/ml, tumor poor differentiation (grade 3–4), micro and macro vascular tumor invasion, advanced stage (AJCC III-IV, BCLC stage B-C, and CLIP score>2) exhibited a higher risk score (Figure 4). Here, AFP is linked to neoplasm.